A study was conducted in puppies of one litter beginning before they were three weeks old and repeated up to six times in the first four months of life to determine whether any age-related changes in peak plasma lignocaine levels occurred following tracheal spray. These were significantly higher in the youngest group (less than 20 days) than in dogs 2-3 months of age. There was a significant negative correlation between peak plasma levels and age up to four months. The maximum level attained by any puppy was 4.48 ug/ml after 4 mg/kg tracheal lignocaine spray.
Variable plasma levels of lignocaine have been recorded after tracheal spray in children. Pelton et al. reported peak arterial levels of 3.2 JAg/ml following 3 mg/kg in children. I A preliminary study by our group obtained higher peak levels in young children,2 but extension of that work has shown that high levels occur sporadically throughout childhood with our method of application using a Cass needle. J We decided to study a group of puppies from a young age (less than 20 days) and then restudy the same animals periodically for 3 to 4 months to determine whether there were changes, as they grew, in the peak plasma lignocaine levels and time from spraying until peak levels were reached. thiopentone, alcuronium (0.05 mg/kg), intubated and ventilated with nitrous oxide and oxygen using a Starling pump. Arterial pressure, end-expired CO 2 and oesophageal temperature were monitored. They were kept warm by wrapping in cotton wool and blowing warm air over them, A femoral artery was cannulated with a 22 gauge Medicut cannula. This was used for arterial pressure monitoring and for blood sampling. A forelimb vein was cannulated for the injection of drugs and 20 mllkg of Hartmann's solution was infused prior to the experiment to prevent hypovolaemia from blood sampling. This is likely to occur in small puppies if fluids are not given.
METHODS
Lignocaine 4070 was diluted with sterile water to 2 % so that the volumes would be adequate to spray in the small puppies, 4 mg/kg was sprayed with the Cass needle inserted into the trachea so that the tip was 0.5 cm/kg below the vocal cords. This was done to ensure a standardised tracheal spray. The endotracheal tube was removed transiently during spraying and then reinserted immediately.
A control sample of arterial blood was taken before spraying and then samples (at least 0.6 ml) were taken at 0.5,1,2,3,5,7,8,10,20 and 30 minutes following endotracheal lignocaine. The samples were placed in heparinised tubes, centrifuged and the plasma stored in labelled glass tubes at -20°C. 250 III aliquots of plasma were used for analysis. The plasma lignocaine levels were measured using HPLC with UV detection at 205 nm.4 Figure 1 shows the plots of mean plasma concentration at each sampling time for each J·o :J age group with SEM shown for the two younger groups. It shows that plasma levels decreased with decreasing age. At the 8 and 10 minutes sampling times there was a significant difference between the puppies when less than 20 days old and at all times when older than 20 days. At 2,5,7, minutes a significant difference existed only between the puppies when less than 20 days and at 65-90 days. Concentrations in the oldest group were significantly different from those in the youngest group at 20 minutes. The figure shows the greater variability in plasma concentrations in the early phase suggesting variability in rate of uptake rather than the distribution and elimination phases. Figure 2 shows the peak plasma concentration against age for each experiment. These ranged from 0.23 to 4.48 ~g/ml. There was a significant negative correlation between peak concentration and age (r = -0.486, p<O.OI).
RESULTS
There was no correlation between time to reach the peak concentration and age (r= -0.18S, p<O.OS).
DISCUSSION
This study, using the animals as their own controls as they grew, showed significantly higher peak plasma concentrations at the youngest age and that the peak plasma concentrations tended to decrease with age.
Patel et al. obtained peak arterial and venous concentrations of O.S (SD O.IS) and 1.32 (SD 0.68) ~g/ml respectively at IS and S minutes in adult dogs following lignocaine 3 mg/kg. 5 The higher plasma concentrations in younger dogs could reflect: 1. a greater degree of tracheal absorption; 2. a difference in cardiac output and its distribution, particularly to the liver. (Cardiac output is three times greater in the newborn than in adults when related to weight); 3. less well-developed drug elimination processes; 4. differences in volume of distribution, although these have been shown not to differ significantly with age in puppies studies following the intravenous infusion of lignocaine. 4 The results of this study were consistent with the results of our initial clinical study where young children had higher levels after tracheal spray and where occasional very high peaks were obtained in children under 3 years.2 Subsequently, very high levels occurred sporadically throughout the paediatric age group when a larger number of children were studied. 3 It is not known why absorption is more rapid and greater in some subjects, but factors such as the site of absorption (trachea, bronchi, small airways or alveoli), the state of the mucosa, the type of ventilation and the rate and method of local anaesthetic instillation may all be factors causing variation. In this study we attempted to control site of application, volume of lignocaine in relation to size, the anaesthetic and the type of ventilation (controlled).
